在患有 Myasthenia Gravis 的患者中,与发病时的年龄相关的结果
Xiaoyu Huang1, Zi-Hao Yu2, Ying Cui2
1Department of Neurology, Tianjin Medical University General Hospital, China.
Neurology
|November 20, 2025
概括
这项研究表明,肌痛性骨髓灰质炎 (MG) 患者根据发病时的年龄有不同的特征和结果. 晚期发作的MG显示出更糟糕的预后,突出了不同的患者群体.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 骨髓灰质炎 (MG) 呈现出显著的异质性,受发病年龄的影响.
- 此前中国对MG的研究受限于单中心数据和小样本大小.
- 了解与年龄有关的差异对于有效的MG管理至关重要.
研究的目的:
- 为了比较不同年龄组的MG患者的临床特征,治疗反应和长期结果.
- 确定与每个年龄小组相关的特定风险因素和预后指标.
- 提供一个全面的,多中心分析中国的MG异质性.
主要方法:
- 一个观察性,横截面,多中心,回顾性研究.
- 从中国三个中心 (2012-2022) 审查了2574名MG患者的医疗记录.
- 将患者分为青少年 (<18岁),早期发病 (18-49岁) 和晚期发病 (≥50岁) 分组.
主要成果:
- 青少年MG (39.7%) 在幼儿时期达到顶峰,主要是眼部,并且大多对治疗有反应.
- 晚期发病的MG (38.2%) 显示男性占主导地位,并发病率较高,达到最小表现 (MM) 或更好的状态的比例较低 (66.7%vs74.7%).
- 与较差的结果相关的因素包括晚期发作的MG,胸膜异常和普遍的MG.
结论:
- 发病时的年龄显著影响了肌痛性骨髓灰质炎的临床表现和预后.
- 青春期发病的青少年MG和晚期发病的MG被确定为脆弱群体.
- 晚期发作的MG与较差的长期预后有关,需要量身定制的管理策略.
相关概念视频
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Disorders of the Skeletal Muscle
1.7K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.7K
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
223
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
223
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
186
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
186


